Ignite Creation Date:
2025-12-24 @ 3:41 PM
Ignite Modification Date:
2025-12-29 @ 1:45 PM
Study NCT ID:
NCT01076192
Status:
COMPLETED
Last Update Posted:
2016-01-06
First Post:
2010-02-24
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Adalimumab (HUMIRA®) in Patients With Moderate to Severe Psoriasis (PS) in Spain (PROMISE)
Sponsor:
AbbVie (prior sponsor, Abbott)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-02
Start Date Type:
None
Primary Completion Date:
2014-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-09
Completion Date Type:
ACTUAL
First Submit Date:
2010-02-24
First Submit QC Date:
None
Study First Post Date:
2010-02-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-09-25
Results First Submit QC Date:
None
Results First Post Date:
2016-01-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-12-01
Last Update Post Date:
2016-01-06
Last Update Post Date Type:
ESTIMATED